Clinical Operations
Buenos Aires, Argentina
Be the catalyst that brings clinical trials to life. Navigate regulatory complexities, partner with health authorities and ethics committees, and ensure studies launch successfully.
Your new role
As a Study Start-Up Analyst, you'll own the end-to-end execution of study start-up and submission activities for assigned clinical trials. You'll be the regulatory expert who ensures everything is in place for trials to launch on time and in full compliance.
Your responsibilities will include:
Your new department
Within Clinical Operations, you'll join a dynamic Study Start-Up team that sits at the critical juncture between trial design and execution. Your work will enable trials to launch, collaborating with global project teams and local stakeholders to turn research plans into reality.
Your skills & qualifications
We're looking for a clinical regulatory professional who combines technical expertise with strong stakeholder management and a solutions-oriented mindset. You'll need:
Working at Novo Nordisk
For over 100 years, we've been committed to defeating serious chronic diseases. Our work in clinical research is at the heart of this mission—each trial you help launch represents hope for patients living with diabetes, obesity, and other serious conditions. You'll be part of a global community that values precision, quality, and collaboration. Here, your regulatory expertise matters, your attention to detail makes a difference, and your ability to navigate complexity helps bring innovative treatments to millions of patients worldwide. If you're ready to apply your skills in an environment where the work is challenging and the impact is real, this is your opportunity.
Deadline
Apply before May 8th. Applications will be reviewed on an ongoing basis.
We commit to an inclusive recruitment process and equality of opportunity for all our job applicants.
We’re not your typical healthcare company. In a modern world of quick fixes, we focus on solutions to defeat serious chronic diseases and promote long-term health. Our unordinary mindset is at the heart of everything we do. We seek out new ideas and put people first as we push the boundaries of science, make healthcare more accessible, and treat, prevent, and even cure diseases that affect millions of lives. Because it takes an unordinary approach to drive real, lasting change in health.

We’re not your typical healthcare company. In a modern world of quick fixes, we focus on solutions to defeat serious chronic disease and create long-term health.
Our unordinary mindset is at the heart of everything we do. We seek out new ideas and put people first as we push the boundaries of science, make healthcare more accessible, and work to treat, prevent, and even cure diseases that affect millions of lives. Founded in Denmark in 1923, today we employ more than 77,000 people in 80 offices around the world – all united by our bold purpose to drive change to defeat serious chronic diseases. Want to learn more? Visit www.novonordisk.com.
This page isn’t intended for discussions about products. As such, postings or comments that contain product discussions may be removed. This page is for discussions about Novo Nordisk and its subsidiaries and the initiatives and projects we are involved in. While we welcome everyone to make comments, we reserve the right to remove those that are off-topic, abusive or intended to spam.
Any questions specific to products should be made to your healthcare professional. If you wish to file an adverse drug reaction please contact Novo Nordisk’s office in the country you live in:
https://www.novonordisk.com/contact-us/find-local-information.html
For other customer complaints, please contact us here:
https://www.novonordisk.com/contact-us.html
Please keep in mind that Novo Nordisk A/S and its subsidiaries work within a highly regulated industry. Therefore, comments that pertain to legal matters or regulatory issues may be removed.
Comments contained on this site come from members of the public, and do not necessarily reflect the views of Novo Nordisk A/S. Novo Nordisk A/S does not endorse or approve any content added by other LinkedIn users.
Learn more about our privacy disclaimer and community guidelines here: https://www.novonordisk.com/data-privacy-and-user-rights/social-media-privacy-disclaimer.html